| # | Drug | Count |
|---|---|---|
| 0 | TRASTUZUMAB | 1263 |
| 1 | DOCETAXEL | 787 |
| 2 | DOCETAXEL ANHYDROUS | 787 |
| 3 | LISINOPRIL | 658 |
| 4 | DROSPIRENONE AND ETHINYL ESTRADIOL | 589 |
| 5 | DOXORUBICIN | 520 |
| 6 | METFORMIN | 508 |
| 7 | CARBOPLATIN | 504 |
| 8 | METFORMIN ER 500 MG | 488 |
| 9 | METFORMIN ER 750 MG | 488 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PEGFILGRASTIM | 400 | 0.0334 |
| 1 | EPIRUBICIN HYDROCHLORIDE | 174 | 0.0268 |
| 2 | POLYETHYLENE GLYOCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE | 3 | 0.0242 |
| 3 | TRASTUZUMAB | 1263 | 0.0182 |
| 4 | DROSPIRENONE AND ETHINYL ESTRADIOL | 589 | 0.0134 |
| 5 | SERTACONAZOLE NITRATE | 2 | 0.0123 |
| 6 | APREPITANT | 90 | 0.0120 |
| 7 | DOCETAXEL | 787 | 0.0116 |
| 8 | DOCETAXEL ANHYDROUS | 787 | 0.0116 |
| 9 | PROTAMINE SULFATE | 21 | 0.0114 |
| # | Drug class | Count |
|---|---|---|
| 0 | HER2/neu Receptor Antagonist [EPC] | 1269 |
| 1 | Benzodiazepine [EPC] | 942 |
| 2 | Microtubule Inhibitor [EPC] | 842 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 761 |
| 4 | Aromatase Inhibitor [EPC] | 645 |
| 5 | Corticosteroid [EPC] | 621 |
| 6 | Platinum-based Drug [EPC] | 512 |
| 7 | Leukocyte Growth Factor [EPC] | 452 |
| 8 | Proton Pump Inhibitor [EPC] | 439 |
| 9 | Alkylating Drug [EPC] | 437 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | HER2/neu Receptor Antagonist [EPC] | 1269 | 0.0170 |
| 1 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 91 | 0.0104 |
| 2 | Provitamin D2 Compound [EPC] | 188 | 0.0063 |
| 3 | Aromatase Inhibitor [EPC] | 645 | 0.0057 |
| 4 | Guanylate Cyclase-C Agonist [EPC] | 11 | 0.0053 |
| 5 | Microtubule Inhibitor [EPC] | 842 | 0.0051 |
| 6 | Osmotic Diuretic [EPC] | 23 | 0.0044 |
| 7 | Potassium-sparing Diuretic [EPC] | 58 | 0.0043 |
| 8 | Phenothiazine [EPC] | 125 | 0.0042 |
| 9 | Leukocyte Growth Factor [EPC] | 452 | 0.0032 |